Kramer, William G.
Kramer Consulting, LLC, North Potomac, Maryland, USA
3 papers on CoChat
Most cited papers
- Verified
Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia
Wun, T., Styles, L., DeCastro, L., Telen, M. J., Kuypers, F., Cheung, A., Kramer, W., Flanner, H., Rhee, S., Magnani, J. L., et al. (2014) · PLoS ONE
Hemoglobinopathies and Related DisordersBlood properties and coagulation
Cited by 69
- Verified
Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy Volunteers
Hodges, M. R., Ople, E., Wedel, P., Shaw, K. J., Jakate, A., Kramer, W. G., Marle, S. V., van Hoogdalem, E.-J., & Tawadrous, M. (2023) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 52
- Verified
Ocular distribution of cyclosporine following topical administration of OTX-101 in New Zealand white rabbits
Weiss, S. L., & Kramer, W. G. (2019) · Journal of Ocular Pharmacology and Therapeutics
Ocular Surface and Contact LensAdvanced Drug Delivery Systems
Cited by 41
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free